Answers are grounded in this paper and cite their sources.
Psychoactive medications can alter the occurrence, latency and EEG characteristics of specific sleep/dream states. CNS active drugs are increasingly being defined by the EEG effects associated with the behavioural effects which they produce. Most disorders of dreaming, parasomnias, and the symptom complexes of a variety of medical disorders are sleep-state-specific, occurring only in one of the electrophysiologically defined sleep stages. Clinical depression produces a decrease in REMS and REMS latency. The effects of CNS active medications can be correlated with alterations in specific states of sleep and dreaming induced by medical and psychiatric disorders. Sleep states can be pharmacologically altered, reduced or eliminated. A framework of sleep-stage-specific drug effects can be used to explain and suggest appropriate therapies for treating sleep/dream-state-specific disorders and symptoms.
No takes yet. Share an insight, caveat, or question.
J.F. Pagel (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: